Heparin-Induced Thrombocytopenia With a False Negative Anti-PF4 Assay.

IF 0.7
Vascular and endovascular surgery Pub Date : 2026-05-01 Epub Date: 2025-11-05 DOI:10.1177/15385744251395139
Thomas J Perry, Bryan Cass, Ryan Ellis, Ali Khalifeh
{"title":"Heparin-Induced Thrombocytopenia With a False Negative Anti-PF4 Assay.","authors":"Thomas J Perry, Bryan Cass, Ryan Ellis, Ali Khalifeh","doi":"10.1177/15385744251395139","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Heparin-induced thrombocytopenia (HIT) is an acquired prothrombotic state from anti-heparin platelet-factor 4 (PF4) mediated activation of platelets. Anti-PF4 assay is used to screen for HIT due to high sensitivity and negative predictive value. <b>Case Report:</b> We present a 74-year-old male that had clinical HIT with false negative anti-PF4 and subsequently positive serotonin release assay (SRA). Delay in cessation of heparin led to recurrent limb thrombosis in the setting of multiple revascularization attempts with a poor outcome. <b>Conclusion:</b> We re-emphasize the importance of clinical presentation in management of patients with suspected HIT.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"358-360"},"PeriodicalIF":0.7000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular and endovascular surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15385744251395139","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Heparin-induced thrombocytopenia (HIT) is an acquired prothrombotic state from anti-heparin platelet-factor 4 (PF4) mediated activation of platelets. Anti-PF4 assay is used to screen for HIT due to high sensitivity and negative predictive value. Case Report: We present a 74-year-old male that had clinical HIT with false negative anti-PF4 and subsequently positive serotonin release assay (SRA). Delay in cessation of heparin led to recurrent limb thrombosis in the setting of multiple revascularization attempts with a poor outcome. Conclusion: We re-emphasize the importance of clinical presentation in management of patients with suspected HIT.

肝素诱导的血小板减少伴假阴性抗pf4测定。
背景:肝素诱导的血小板减少症(HIT)是由抗肝素血小板因子4 (PF4)介导的血小板活化而获得的血栓形成前状态。抗pf4检测灵敏度高,阴性预测值高,可用于HIT筛查。病例报告:我们提出了一个74岁的男性,有临床HIT假阴性抗pf4和随后的血清素释放试验(SRA)阳性。在多次血运重建尝试中,延迟停止肝素导致肢体血栓复发,预后不佳。结论:我们再次强调临床表现在治疗疑似HIT患者中的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书